FDA Inspection
Kofinas Fertility GroupFDA Inspection 1122513 - Kofinas Fertility Group - February 13, 2020
Record Details
This FDA Inspection record concerns Kofinas Fertility Group, with an inspection on February 13, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Kofinas Fertility Group
- Inspection Date
- February 13, 2020
- Product Type
- Biologics
View Company Profile
ID · 12bd4e9a-818b-449b-9c8b-430e6e47cde4
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1122513
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Kofinas Fertility Group
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 9, 2025 | VAI | New York District Office | Human Cellular, Tissue, and Gene Therapies |
| July 25, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 25, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 11, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 4, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Kofinas Fertility Group
- FDA Inspection 1266536 - 2025-04-09
- FDA Inspection 1210757 - 2023-07-25
- FDA Inspection 1056801 - 2018-06-25
- FDA Inspection 963390 - 2016-03-11
- FDA Inspection 857553 - 2013-12-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.